Robert Seeger, MD, Pediatric Hematology & Oncology, Los Angeles, CA, Children's Hospital Los Angeles

RobertCharlesSeegerMD

Pediatric Hematology & Oncology Los Angeles, CA

Professor, Pediatrics, USC School of Medicine

Dr. Seeger is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Seeger's full profile

Already have an account?

Education & Training

  • University of Minnesota at Fairview
    University of Minnesota at FairviewRESIDENCY
  • Oregon Health & Science University School of Medicine
    Oregon Health & Science University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - 2022
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma
    Telomere Trimming and DNA Damage as Signatures of High Risk NeuroblastomaMay 23, 2020
  • Removing the Enablers
    Removing the EnablersApril 26, 2018
  • CHLA Is Awarded More Than $1 Million from St. Baldrick’s Foundation to Fund Cancer Research
    CHLA Is Awarded More Than $1 Million from St. Baldrick’s Foundation to Fund Cancer ResearchNovember 13, 2017
  • Join now to see all

Grant Support

  • Natural Killer Cell Based ImmunotherapyNational Cancer Institute2010–2011
  • Gene Expression Of Neuroblastoma And Normal Cells In Bone Marrow Predicts OutcomeNational Cancer Institute2010–2011
  • Research Support ServicesNational Cancer Institute2005–2011
  • Biology And Therapy Of High Risk NeuroblastomaNational Cancer Institute2005–2011
  • Clinical Correlative Studies Of NeuroblastomaNational Cancer Institute2002–2010
  • ImmunotherapyNational Cancer Institute2005–2009
  • Biology And Therapy Of High-Risk NeuroblastomaNational Cancer Institute2000–2004
  • Pilot--Developmental Therapeutics And Clinical TrialsNational Cancer Institute2001–2002
  • Immunocytokine TherapyNational Cancer Institute2000–2002
  • Core--Research Support ServicesNational Cancer Institute2000–2002
  • Phase I Study--Chimeric Human /Murine Anti-Gd2 MAB With Bm-Csf In NeuroblastomaNational Center For Research Resources1997–2002
  • Phase 1 Study Of Human Gamma Interferon Gene-Transduced Tumor CellsNational Center For Research Resources1996–2002
  • Clinical Correlative Studies Of NeuroblastomaNational Cancer Institute1998–2001
  • Human Neuroblastoma AntigensNational Cancer Institute1988–2000
  • Clinical Correlative Studies Of NeuroblastomaNational Cancer Institute1993–1996
  • Immunocytology Of Marrow Metastases In NeuroblastomaNational Cancer Institute1990–1991
  • Human Neuroblastoma AntigensNational Cancer Institute1985–1988

Hospital Affiliations